These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25726573)

  • 21. Japanese encephalitis: the need for a more effective vaccine.
    Marfin AA; Gubler DJ
    Lancet; 2005 Oct 15-21; 366(9494):1335-7. PubMed ID: 16226596
    [No Abstract]   [Full Text] [Related]  

  • 22. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
    Halstead SB; Thomas SJ
    Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
    Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E
    Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.
    Jelinek T
    Expert Rev Vaccines; 2013 Aug; 12(8):859-69. PubMed ID: 23984958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese encephalitis: update on vaccines and vaccine recommendations.
    Wilder-Smith A; Halstead SB
    Curr Opin Infect Dis; 2010 Oct; 23(5):426-31. PubMed ID: 20581670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of viremia formation between guinea-pigs infected with wild and attenuated (SA14-14-2) Japanese encephalitis viruses].
    Liu XY; Yu YX; Xu HS; Liang GD; Wang HY; Jia LL; Dong GM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):343-5. PubMed ID: 21280319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.
    Rabe IB; Miller ER; Fischer M; Hills SL
    Vaccine; 2015 Jan; 33(5):708-12. PubMed ID: 25498208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine.
    Wkly Epidemiol Rec; 1994 Apr; 69(16):113-8. PubMed ID: 8003406
    [No Abstract]   [Full Text] [Related]  

  • 32. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
    Srivastava AK; Putnak JR; Lee SH; Hong SP; Moon SB; Barvir DA; Zhao B; Olson RA; Kim SO; Yoo WD; Towle AC; Vaughn DW; Innis BL; Eckels KH
    Vaccine; 2001 Aug; 19(31):4557-65. PubMed ID: 11483284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
    Tauber E; Kollaritsch H; von Sonnenburg F; Lademann M; Jilma B; Firbas C; Jelinek T; Beckett C; Knobloch J; McBride WJ; Schuller E; Kaltenböck A; Sun W; Lyons A
    J Infect Dis; 2008 Aug; 198(4):493-9. PubMed ID: 18588481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
    Choi UY; Lee SY; Kim KH; Kim DS; Choi KM; Cha SH; Kang JH
    J Trop Pediatr; 2013 Oct; 59(5):423-5. PubMed ID: 23764540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of Japanese encephalitis vaccines.
    Hu YL; Lee PI
    Hum Vaccin Immunother; 2021 Nov; 17(11):4259-4264. PubMed ID: 34613870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012.
    Trent DW; Minor P; Jivapaisarnpong T; Shin J;
    Biologicals; 2013 Nov; 41(6):450-7. PubMed ID: 23891495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
    Zeng M; Jia LL; Yu YX; Dong GM; Liu WX; Wang ZW; Li DF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):9-11. PubMed ID: 16201461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].
    Ma FB; Zheng L; Bi C; Tao H; Zhou YL; Zhang JL; Tang FY; Xie P; Zheng CZ; Peng WB; Jiang RJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):113-5. PubMed ID: 12697111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.